Drugmakers Reap Billions Meeting Covid-19 Needs

Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable.

Related Keywords

California ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Switzerland ,Massachusetts ,San Francisco ,Astrazeneca Covid ,Stephane Bancel ,Bloomberg Abbott Laboratorie Binaxnow ,Jareds Hopkins ,Denise Roland ,Albert Bourla ,Roche Covid ,Joseph Walker ,Abbott Laboratorie Binaxnow ,Ronny Gal ,Bloomberg ,Regeneron Pharmaceuticals Inc ,Eli Lilly Co ,Pfizer ,Astrazeneca ,Pfizer Inc ,Moderna Inc ,Abbott Laboratories ,Roche Holding ,Abbott Laboratorie Binaxnow Ag Card ,Wall Street Journal ,Eli Lilly ,Regeneron Pharmaceuticals ,Wall Street ,York Based Pfizer ,Mizuho Americas ,The Wall Street Journal ,